An Emerging Leader In Cancer Diagnostics

Cancer Genetics, Inc. (CGI) is an emerging leader in personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual.

Products being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state of the art reference lab provide genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.

CGI’s state of the art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited. In addition we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey. Our leading-edge test menu is entirely focused on oncology and provides insights and clarity to inform and guide personalized cancer treatment.

Founded in 1999 by world-renowned cytogeneticist Dr. R.S.K. Chaganti, CGI’s scientific advisory board includes leading specialists in clinical cytogenetics, as well as significant thought leaders capable of driving adoption in the tri-state area.

The company has been built upon a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, as well as strong academic relationships with major cancer centers such as Memorial Sloan-Kettering and the National Cancer Institute.